These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24195355)

  • 21. Vaccination against classical swine fever virus: limitations and new strategies.
    Greiser-Wilke I; Moennig V
    Anim Health Res Rev; 2004 Dec; 5(2):223-6. PubMed ID: 15984328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
    Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S
    Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain.
    Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ
    Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel marker vaccines against classical swine fever.
    Beer M; Reimann I; Hoffmann B; Depner K
    Vaccine; 2007 Jul; 25(30):5665-70. PubMed ID: 17239502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China.
    Luo Y; Ji S; Lei JL; Xiang GT; Liu Y; Gao Y; Meng XY; Zheng G; Zhang EY; Wang Y; Du ML; Li Y; Li S; He XJ; Sun Y; Qiu HJ
    Vet Microbiol; 2017 Mar; 201():154-161. PubMed ID: 28284603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals.
    Kortekaas J; Ketelaar J; Vloet RP; Loeffen WL
    Vet Microbiol; 2011 Jan; 147(1-2):11-8. PubMed ID: 20541334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
    Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
    Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, diagnosis and control of classical swine fever: Recent developments and future challenges.
    Postel A; Austermann-Busch S; Petrov A; Moennig V; Becher P
    Transbound Emerg Dis; 2018 May; 65 Suppl 1():248-261. PubMed ID: 28795533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability.
    Holinka LG; Fernandez-Sainz I; Sanford B; O'Donnell V; Gladue DP; Carlson J; Lu Z; Risatti GR; Borca MV
    Virology; 2014 Dec; 471-473():13-8. PubMed ID: 25461526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination.
    Blome S; Aebischer A; Lange E; Hofmann M; Leifer I; Loeffen W; Koenen F; Beer M
    Vet Microbiol; 2012 Jul; 158(1-2):42-59. PubMed ID: 22397931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Oral Bait Vaccine Efficacy Against Classical Swine Fever in Village Backyard Pig Farms in Bhutan.
    Monger VR; Stegeman JA; Dukpa K; Gurung RB; Loeffen WL
    Transbound Emerg Dis; 2016 Dec; 63(6):e211-e218. PubMed ID: 25660486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
    Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
    Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV.
    Gao F; Jiang Y; Li G; Zhou Y; Yu L; Li L; Tong W; Zheng H; Zhang Y; Yu H; Shan T; Yang S; Liu H; Zhao K; Tong G
    Vaccine; 2018 May; 36(23):3269-3277. PubMed ID: 29724508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs.
    Lei JL; Xia SL; Wang Y; Du M; Xiang GT; Cong X; Luo Y; Li LF; Zhang L; Yu J; Hu Y; Qiu HJ; Sun Y
    Immunol Lett; 2016 Jun; 174():63-71. PubMed ID: 27113530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors critical for successful vaccination against classical swine fever in endemic areas.
    Suradhat S; Damrongwatanapokin S; Thanawongnuwech R
    Vet Microbiol; 2007 Jan; 119(1):1-9. PubMed ID: 17097243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and Characterization of a Moderately Virulent Classical Swine Fever Virus Emerging in China.
    Luo Y; Ji S; Liu Y; Lei JL; Xia SL; Wang Y; Du ML; Shao L; Meng XY; Zhou M; Sun Y; Qiu HJ
    Transbound Emerg Dis; 2017 Dec; 64(6):1848-1857. PubMed ID: 27658930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studying classical swine fever virus: making the best of a bad virus.
    Ji W; Guo Z; Ding NZ; He CQ
    Virus Res; 2015 Feb; 197():35-47. PubMed ID: 25510481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single dose of the novel chimeric subunit vaccine E2-CD154 confers early full protection against classical swine fever virus.
    Suárez M; Sordo Y; Prieto Y; Rodríguez MP; Méndez L; Rodríguez EM; Rodríguez-Mallon A; Lorenzo E; Santana E; González N; Naranjo P; Frías MT; Carpio Y; Estrada MP
    Vaccine; 2017 Aug; 35(34):4437-4443. PubMed ID: 28688785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection.
    Ganges L; Núñez JI; Sobrino F; Borrego B; Fernández-Borges N; Frías-Lepoureau MT; Rodríguez F
    Vet J; 2008 Aug; 177(2):169-77. PubMed ID: 17804267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.